Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review

机译：基于血液的蛋白质特征可用于大肠癌的早期检测：系统评价

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives:Blood-based proteins might be an attractive option for early detection of colorectal cancer (CRC), but individually they are unlikely to achieve the diagnostic performance required for population based screening. We aimed at summarizing current evidence of diagnostic performance of signatures based on multiple proteins for early detection of CRC.

机译：目的：基于血液的蛋白质可能是早期检测结直肠癌（CRC）的有吸引力的选择，但单独地，它们不太可能达到基于人群的筛查所需的诊断性能。我们旨在总结基于多种蛋白质的CRC早期检测的签名诊断性能的当前证据。

著录项

期刊名称 Clinical and Translational Gastroenterology
作者
Megha Bhardwaj; Anton Gies; Simone Werner; Petra Schrotz-King; Hermann Brenner;
展开▼
作者单位

展开▼
年(卷),期 2017(8),11
年度 2017
页码 e128
总页数 10
原文格式 PDF
正文语种
中图分类肠道病毒与肝炎病毒;肝及胆疾病;肠疾病;
关键词
入库时间 2022-08-17 13:03:32

相似文献

外文文献
中文文献
专利

1. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review [J] . Petit Joel, Carroll Georgia, Gould Tiffany, Journal of Surgical Research: Clinical and Laboratory Investigation . 2019,第期

机译：无细胞DNA作为结直肠癌的诊断血液生物标志物：系统评价
2. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis [J] . Jane VCarter, Norman JGalbraith, DongyanYang, British Journal of Cancer . 2017,第6期

机译：基于血液的微小RNA作为大肠癌诊断的生物标志物：系统评价和荟萃分析
3. The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review [J] . Ian A. Cree, Lesley Uttley, Helen Buckley Woods, BMC Cancer . 2017,第1期

机译：循环肿瘤DNA血液生物标记物用于癌症早期检测的证据基础：系统的作图综述
4. Diagnostic, prognostic, and predictive plasma protein biomarker signatures of colorectal cancer [C] . S. Surinova, Ch.- Y. Chang, T. Clough, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2012

机译：结直肠癌的诊断，预测和预测性血浆蛋白生物标志物签名
5. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies in breast, lung, colorectal, ovarian, and endometrial cancer [D] . Dahabreh, Issa J. 2011

机译：rs1042522 TP53（Arg72Pro）多态性的遗传关联研究中的基因型错误分类：对乳腺癌，肺癌，结直肠癌，卵巢癌和子宫内膜癌研究的系统评价
6. Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis [O] . Jiayun Nian, Xu Sun, SuYang Ming, 2017

机译：甲基化SEPT9在基于血的大肠癌检测中的诊断准确性：系统评价和荟萃分析
7. Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review [O] . Megha Bhardwaj, Anton Gies, Simone Werner, 2017

机译：基于血液的蛋白质签名，用于早期检测结直肠癌：系统评价
8. Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia. Technology Assessment Report [R] . Terasawa, T., Dahabreh, I., Castaldi, P. J., 2010

机译：针对癌症治疗的选定药物遗传学测试的系统评价：CYp2D6用于乳腺癌中的他莫昔芬，KRas用于结肠直肠癌中的抗EGFR抗体，以及BCR-aBL1用于慢性髓性白血病中的酪氨酸激酶抑制剂。技术评估报告

Blood-Based Protein Signatures for Early Detection of Colorectal Cancer: A Systematic Review

摘要

著录项

相似文献

相关主题

期刊订阅